Callitas Health Inc. Aktie Deutsche Boerse AG
Aktien
A2GSU1
CA13125C1068
T3F3
Biotechnologie
Umsatz 2018 | 0.75 0.7 0.68 | Umsatz 2019 | 0.71 0.66 0.64 | Marktwert | 3.53 Mio. 3.3 Mio. 3.2 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -4.68 Mio. -4.54 Mio. | Nettoergebnis 2019 | -1 Mio. -936’891 -908’530 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 298’859 289’812 | Nettoschuld 2019 | 847’693 794’196 770’155 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
-1.78% | 41.36 Mrd. | |
+45.49% | 41.3 Mrd. | |
+4.01% | 39.61 Mrd. | |
-15.14% | 25.62 Mrd. | |
+3.16% | 24.09 Mrd. | |
-24.08% | 18.38 Mrd. | |
-2.67% | 11.82 Mrd. | |
+24.76% | 11.85 Mrd. | |
+7.01% | 11.07 Mrd. |